Glenn Muir Net Worth & Insider Trades

Glenn Muir G1 Therapeutics, Inc

As of June 24, 2022

What is Glenn Muir's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's Glenn Muir is estimated to be about $84.95M . Glenn Muir owns about 170,969 units of G1 Therapeutics, Inc common stock. In the last 5 years at G1 Therapeutics, Inc, Glenn Muir has sold an estimated value of $0 worth.

What is Glenn Muir's Past Insider Trading?

Glenn Muir's largest purchase order was 50,000 units , worth over $675K on November 19, 2020. In total, Glenn Muir has made about 8 transactions over 5 years of their time at G1 Therapeutics, Inc. Glenn Muir usually trades in June, with the busiest year in 2020 and 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Glenn Muir's' Mailing Address?

  • Mailing address is C/o Hologic, Inc. Bedford MA 01730 MA

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on October 20, 2022 by Mark Velleca who sold 15,000 units worth $175.49K . In the last 5 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.42M and bought an estimated value of $25.76M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1